S. Aghamuradov

Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine

G. Can, G. Hatemi, A. Gul, 2022, Journal of medical virology.

Reinfection with SARS‐CoV‐2 in a kidney transplant recipient

A. Gul, E. Demir, A. Turkmen, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

S. Ünal, A. Çağatay, M. Bayram, 2021, Rheumatology International.

Criteria for hyperinflammation developing in coronavirus disease‐19: analysis of two cohorts from different periods of the pandemic

A. Gül, M. Kose, S. Kalayoglu-besisik, 2022, Arthritis & rheumatology.

POS1259 FAVOURABLE SHORT-TERM COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS

M. Inanç, A. Gül, N. Koca, 2021 .